KDIGO 2026 Guidelines: Diabetes & CKD Updates

Created using ChatSlide

This presentation offers a comprehensive overview of the KDIGO 2026 updates, emphasizing the purpose and scope of these updates with a keen focus on evidence-based methodology. Key updates include refined definitions for diabetes-related kidney risk assessments, advanced glycemic monitoring through Hemoglobin A1c and continuous glucose monitoring (CGM), and novel pharmacotherapy strategies integrating lifestyle modifications and drug therapy like SGLT2 inhibitors. With supporting visuals,...